Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study

Claudio Bonifati(San Gallicano Hospital), Antonio Costanzo, Matteo Megna(University of Padua), Leonardo Zichichi(Ospedale Sant Antonio), Claudia Lasagni(University of Modena and Reggio Emilia), Paolo Dapavo(University of Turin), Luca Stingeni(University of Perugia), Serena Lembo(University of Naples Federico II), Massimo Donini(University of Milan), Antonio Giovanni Richetta, Martina Burlando(Martin University), Talia Gramiccia(Janssen (Italy)), Concetta Potenza(Danieli (Italy)), Maria Rita Bongiorno(University of Palermo), Monica Corazza(University of Ferrara), Giuseppe Stinco(Unknown), Franco Rongioletti(Vita-Salute San Raffaele University), Paola Savoia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Sabatino Pallotta(IRCCS Policlinico San Donato), Claudio Guarneri(University of Messina), Giuseppe Micali(Centro Neurolesi Bonino Pulejo), Stefano Piaserico(University of Padua), Vito Giuseppe Di Lernia(Azienda Usl 8 Arezzo), Ketty Peris, Marco Galluzzo, Annamaria Offidani, Giuseppe Argenziano, Federico Saibene, Laura Atzori, Carlo Giovanni Carrera, Maria Concetta Fargnoli, Federico Bardazzi, Francesca Prignano, Francesca Satolli, Claudia Giofrè, Manuela Papini(University of Perugia), Marco Romanelli, Francesco Loconsole(University of Bari Aldo Moro)
Figshare
January 1, 2026
Cited by 0


Related Papers